GGrantIndex
Sort

89,613 grants matching depression

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)

$992,308
Paul B Rosenberg · Johns Hopkins University · R01 · FY2021 · AG

Cornell ACISR for Late Life Depression

$992,232
Weill Medical College Of Cornell Univ · P30 · FY2003 · MH

Sleep to Reduce Incident Depression Effectively in Peripartum - (STRIDE P)

$992,063
Christopher L Drake · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · MH

CLINICAL COORDINATING CENTER

$991,926
Peter B Cotton · Medical University Of South Carolina · U01 · FY2007 · DK

2/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

$991,848
Warren D Taylor · Vanderbilt University Medical Center · R01 · FY2020 · MH

2/3: Recurrence markers, cognitive burden and neurobiological homeostasis in late-life depression (REMBRANDT)

$991,587
Carmen Andreescu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · MH

Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability

$991,442
David C Glahn · Boston Children'S Hospital · U01 · FY2020 · MH

Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease

$991,394
Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2016 · MH

Biosynthesis, Processing And Secretion of Neuropeptides And Pituitary Hormones

$990,545
Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD

Robust Classification Methods for Categorical Regression

$990,520
Steven S Henley · Martingale Research Corporation · R44 · FY2010 · CA

Automating and Obtaining FDA Approval for a Digital Intervention for Depression

$990,519
Ellen Frank · Health Rhythms, Inc. · R44 · FY2023 · MH

Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study

$990,460
Jeannette R Ickovics · Yale University · R01 · FY2008 · MH

Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers: A Phase 1 Trial Demonstrating Analgesic Superiority of Omnitram to Tramadol in Subjects Coadministered Paroxetine

$990,418
Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2016 · DA

Brain Health and Ethnic Disparities in ADRD Risk: The Case of Arab Americans

$990,293
Toni Claudette Antonucci · University Of Michigan At Ann Arbor · R01 · FY2025 · AG

Attack Major Source of Abused Opioids: Molecularly Deactivate Unused Rx Opioids

$990,284
Thomas E Jenkins · Elysium Therapeutics, Inc. · R44 · FY2019 · DA

Operations, Clinical Assessments and Adminstrative Core

$990,190
Charles B Nemeroff · Emory University · P50 · FY2007 · MH

PDE4B Inhibitors For Treating Major Depression

$989,992
Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2014 · MH

Building collaborative research infrastructure to reduce oral health disparities

$989,922
Susan T Reisine · University Of Connecticut Sch Of Med/Dnt · RC4 · FY2010 · DE

Opioid-Sparing pain management for Chronic Low Back Pain patients using TMC-CP01 - A VANISH (Virtual Autonomic Neuromodulation Induced Systemic Healing) based program

$989,571
Celine Tien · Tamade, Llc · R44 · FY2022 · DA

HEU outcomes: population-evaluation and screening strategies (HOPE)

$989,559
Grace C John-Stewart · University Of Washington · R33 · FY2024 · HD

Mindfulness-based Cognitive Coping Mobile App Intervention for caregivers of individuals with Alzheimer's Disease

$989,297
Bruno Kajiyama · Photozig, Inc. · R44 · FY2022 · AG

Stream Dx: Point of Care Cellular Enabled IoT Communication Hub for Improved Diagnosis, Monitoring, and Post-Treatment Evaluation of LUTS

$988,995
Scott Bradford McClellan · Stream Dx, Inc. · R44 · FY2020 · DK

Studies Of Central Nervous System Functional Anatomy

$988,963
Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2010 · MH

SMART: A Social and Mobile Weight Control Program for Young Adults

$988,153
Kevin Patrick · University Of California, San Diego · U01 · FY2010 · HL

Validating of Machine Learning-Based EEG Treatment Biomarkers in Depression

$988,093
Amit Etkin · Alto Neuroscience, Inc. · R44 · FY2020 · MH